Hypothesis: Comparisons of inter- and intra-individual variations can substitute for twin studies in drug research

Pharmacogenetics

Volumn 8, Issue 4, 1998, Pages 283-289

  Kalow, W ^a   Tang, B K ^a   Endrenyi, L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Genetic component; Heritability; Repeat studies; Variations

Indexed keywords

ACYLTRANSFERASE; ALCOHOL; CAFFEINE; CYTOCHROME P450 ISOENZYME; DEXTROMETHORPHAN; OXAZEPAM; PHENACETIN O DEETHYLASE; XANTHINE OXIDASE;

ANALYTICAL ERROR; DRUG METABOLISM; DRUG RESPONSE; ENZYME ACTIVITY; GENETIC REGULATION; GENETIC VARIABILITY; HERITABILITY; HUMAN; PRIORITY JOURNAL; REVIEW; THEORY; TWINS;

HUMANS; MODELS, GENETIC; PHARMACEUTICAL PREPARATIONS; TWIN STUDIES; VARIATION (GENETICS);

EID: 0031826288     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199808000-00001     Document Type: Review

References (36)

1. Balogh A, Harder S, Volland R, Staib AH. Intra-individual variability of caffeine elimination in healthy subjects. Int J Clin Pharmacol Ther Toxicol 1992; 30:383-387.
2. Denaro CP, Wilson M, Jacob III P, Benowitz NL. Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearance. Clin Pharmacol Ther 1996; 59:284-296.
3. Ereshefsky L, Riesenman C, Lam YWF. Antidepressant drug interactions and the cytochrome P450 system. Clin Pharmacokinet 1995; 29 (suppl 1): 10-19.
4. Fernandez de Gatta M, Garcia J, Lanao JM, Dominguez-Gil A. Bayesian forecasting in paedriatic populations. Clin Pharmacokinet 1996; 31:325-330.
5. Fernandez-Salguero P, Hoffman SMG, Cholerton S et al. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am J Hum Genet 1995; 57:651-660.
6. Fraser AG, Rosalki SB, Gamble GD, Pounder RE. Inter-individual and intra-individual variability of ethanol concentration-time profiles: comparison of ethanol ingestion before and after an evening meal. Br J Clin Pharmacol 1995; 40:387-392.
7. Galton R. The history of twins as a criterium of the relative powers of nature and nurture. J Anthropol Inst 1876; 5:391-406.
8. Gu L, Gonzalez FJ, Kalow W, Tang BK. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 1992; 2:73-77.
9. Kalant H. Pharmacokinetics of ethanol: absorption, distribution, and elimination. In: Begleiter H, Kissin B, editors. The pharmacology of alcohol and alcohol dependence. New York, Oxford. Oxford University Press; 1996. pp. 15-58.
10. Kalow W. Continuous versus polymorphic variation - practical aspects. In: Schlegel J, Hori W, editors. Pharmacogenetics. Bridging the gap between basic science and clinical application. Southborough, MA: IBC Biomedical Library Series; 1996. pp. 4.2.1-4.2.18.
11. Kalow W, Tang BK. Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther 1991; 50:508-519.
12. Kalow W, Tang BK. The use of caffeine for enzyme assays: a critical apraisal. Clin Pharmacol Ther 1993; 53:503-514.
13. Kopun M, Propping P. The kinetics of ethanol absorption and elimination in twins and supplementary repetitive experiments in singleton subjects. Eur J Clin Pharmacol 1977; 11:337-344.
14. Martin NG, Eaves L, Keasey MJ, Davies P. The power of the classical twin study. Heredity 1978; 40:97-116.
15. Martin NG, Perl J, Oakeshott JG, Gibson JB, Starmer GA, Wilks AV. A twin study of ethanol metabolism. Behav Genetics 1985; 15:93-109.
16. Miller CA, Slusher LB, Vesell ES. Polymorphism of theophylline metabolism in man. J Clin Invest 1985; 75:1415-1425.
17. Miller M, Opheim KE, Raisys VA, Motulsky AG. Theophylline metabolism: variation and genetics. Clin Pharmac Ther 1984; 35:170-182.
18. Okey AB. Enzyme induction in the cytochrome P-450 system. In: Kalow W, editor. Pharmacogenetics of drug metabolism: International encyclopedia of pharmacological therapeutics. Section 137. New York: Pergamon Press; 1992. pp. 549-608.
19. Passananti GT, Wolff CA, Vesell ES. Reproducibility of individual rates of ethanol metabolism in fasting subjects. Clin Pharmacol Ther 1990; 47:389-396.
20. Patel M. Genetic variability of an uridine-diphospho-glucuronosyltransferase: UGT2B7 [PhD thesis]. Toronto: University of Toronto; 1997.
21. Patel M, Tang BK, Grant DM, Kalow W. Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam. Pharmacogenetics 1995; 5:287-297.
22. Price Evans DAP. N-Acetyltransferase. In: Kalow W, editor. Pharmacogenetics of drug metabolism: International encyclopedia of pharmacological therapeutics. Section 137. New York: Pergamon Press, Inc; 1992. pp. 95-178.
23. Sesardic D, Boobis AR, Edwards RJ, Davies DS. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br J Clin Pharmacol 1988; 26:363-372.
24. Shahidi NT. Acetophenetidin sensitivity. Am J Dis Child 1967; 113:81-82.
25. Sheiner LB, Ludden TM. Population pharmacokinetics/dynamics. Ann Rev Pharmacol Toxicol 1992; 32:185-209.
26. Simmonds HA, Reiter S, Nishino T. Hereditary xanthinuria. In: Scriver CR, Beaudet AL, Sly WS et al. eds. The Metabolic and molecular bases of inherited disease. 7th ed. Yew York: McGraw-Hill, Inc; 1995. pp. 1781-1797.
27. Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames. Iowa: Iowa State University Press; 1967. pp. 294-296.
28. Tang BK, Kadar D, Li Qian, Iriah J, Yip J, Kalow W. Caffeine as a metabolic probe: validation for its use for acetylator phenotyping. Clin Pharmacol Ther 1991; 49:648-657.
29. Tang BR, Zhou Y, Radar D, Kalow W. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements. Pharmacogenetics 1994; 4:117-124.
30. Thompson JS, Thompson MW. Multifactorial Inheritance. In: Genetics in medicine. Philadelphia: WB Saunders Company; 1986. pp. 210-225.
31. Vesell ES. Pharmacogenetic perspectives gained from twin and family studies. In: Kalow W, editor. Pharmacogenetics of drug metabolism: International encyclopedia of pharmacological therapeutics. Section 137. New York: Pergamon Press; 1992. pp. 845-865.
32. Vesell ES, Page JG, Passananti GT. Genetic and environmental factors afffecting ethanol metabolism in man. Clin Pharmacol Ther 1971; 12:192-201.
33. Vogel F, Motulsky AG. Human genetics. Problems and approaches. 2nd ed. Berlin: Springer-Verging; 1986. pp. 1-807.
34. Weinberg W. Beitraege zur Physiologie und Pathologie der Mehrlingsgeburten beim Menschen. Arch Ges Physiol 1901; 88:346-430.
35. Wilkinson PR. Pharmacokinetics of ethanol: a review. Alcoholism: Clin Exp Res 1980; 4:6-21.
36. Zhou YT. Assessment of caffeine as a probe for CYP1A2 activity [MSc thesis]. Toronto: University of Toronto; 1995.